2seventy bio Inc. (TSVT) Technical Exchange News May 14, 2025, 07:29 UTC 5 2seventy bio Inc. (TSVT) was removed from the list of traded instruments on NASDAQ exchange Comment Full text
TransCode Therapeutics Inc. (RNAZ) Technical Exchange News May 14, 2025, 01:58 UTC 11 NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
Neuroone Medical Technologies Corp (NMTC) Technical Exchange News May 14, 2025, 01:58 UTC 11 NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
HCW Biologics Inc. (HCWB) Technical Exchange News May 14, 2025, 01:58 UTC 10 NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal. Comment Full text
Clene Inc. (CLNNW) Technical Exchange News May 14, 2025, 01:58 UTC 11 NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
Clene Inc. (CLNN) Technical Exchange News May 14, 2025, 01:58 UTC 11 NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
ABVC BioPharma Inc. (ABVC) Technical Exchange News May 14, 2025, 01:58 UTC 12 NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal. Comment Full text
2seventy bio Inc. (TSVT) Technical Exchange News May 14, 2025, 00:12 UTC 5 NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: 2seventy bio, Inc. - Common Stock. Comment Full text
2seventy bio Inc. (TSVT) Technical Exchange News May 14, 2025, 00:12 UTC 6 NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: 2seventy bio, Inc. - Common Stock. Comment Full text
2seventy bio Inc. (TSVT) Technical Exchange News May 14, 2025, 00:12 UTC 6 NASDAQ traded attribute type Security_Name was changed. Previous value: 2seventy bio, Inc. - Common Stock. New value: 2seventy bio, Inc. - Common Stock. Comment Full text